← Back to Search

iParent2Parent Support Program for Solid Organ Transplant Parents

N/A

Recruiting

Led By Samantha J. Anthony, PhD, MSW

Research Sponsored by The Hospital for Sick Children

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to program completion, an average of one year

Awards & highlights

Study Summary

This trial matches parents of pediatric SOT recipients with trained mentors to provide peer support and mentorship. It aims to reduce isolation, improve mental health, and have a long-term positive impact on patient health.

Who is the study for?

This trial is for parents of children under 18 who had a solid organ transplant at least two months ago, or under 21 if they're one year post-transplant. They need to speak English and have access to WhatsApp on a device. To be mentors, they must be recommended by their child's healthcare team.Check my eligibility

What is being tested?

The iParent2Parent Program connects parents of pediatric SOT recipients with trained parent mentors through virtual mentorship. The study will assess whether this program helps reduce isolation and improve mental health among these parents.See study design

What are the potential side effects?

Since the intervention involves peer support and not medical treatment, there are no direct physical side effects expected from participating in the iParent2Parent Program.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to program completion, an average of one year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to program completion, an average of one year

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to program completion, an average of one year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability (Mentees)

Acceptability (Mentors)

Adherence with the iParent2Parent program

+5 more

Secondary outcome measures

Coping (Mentees and Mentors)

Family Functioning (Mentees and Mentors)

Parenting stress (Mentees and Mentors)

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: iParent2Parent ProgramExperimental Treatment1 Intervention

Group II: Standard of Care Waitlist Control GroupActive Control1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

iParent2Parent Program

2019

N/A

~10

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

The Hospital for Sick ChildrenLead Sponsor

692 Previous Clinical Trials

6,946,545 Total Patients Enrolled

2 Trials studying Solid Organ Transplant

115 Patients Enrolled for Solid Organ Transplant

Samantha J. Anthony, PhD, MSWPrincipal InvestigatorThe Hospital for Sick Children

1 Previous Clinical Trials

55 Total Patients Enrolled

Media Library

iParent2Parent Program Clinical Trial Eligibility Overview. Trial Name: NCT05968807 — N/A

Solid Organ Transplant Research Study Groups: Standard of Care Waitlist Control Group, iParent2Parent Program

Solid Organ Transplant Clinical Trial 2023: iParent2Parent Program Highlights & Side Effects. Trial Name: NCT05968807 — N/A

iParent2Parent Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT05968807 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an age restriction for applicants of the experiment?

"This research is seeking out individuals who are in the 18-75 year old age range."

Answered by AI

Who is qualified to be a part of this medical investigation?

"To be considered for inclusion in this research, patients must possess a solid organ transplant and fit within the 18-75 year old demographic. 55 people total are accepted into this study."

Answered by AI

Is there still space available for participants in this research project?

"The trial data hosted on clinicaltrials.gov suggest that this study is no longer in need of participants, as the last update was made on July 28th 2023. Nonetheless, 12 other trials are currently looking for volunteers at this present time."

Answered by AI

What positive results are expected from this investigation?

"This trial, which will span approximately one year from Baseline to completion, seeks to evaluate the efficacy of the iParent2Parent program. Evaluations for Psychological distress (Mentees and Mentors), Perceived social support (Mentees and Mentors) ,and Coping (Mentees and Mentors) are measured with a 8-item questionnaire scored on a scale from 0 to 3; an 6-item questionnaire scored on a scale 1 to 5 producing T scores; and 16 item questionnaires respectively also graded between 0 -3 along with "Did not use" responses that generate scores ranging from 0 – 48. An"

Answered by AI

Recent research and studies

clinicaltrials.govStudy

iParent2Parent Program for Parents of Pediatric Solid Organ Transplant Recipients

Samantha Anthony 2023. "iParent2Parent Program for Parents of Pediatric Solid Organ Transplant Recipients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05968807.